In recent years, Euromed has witnessed stronger demand for its natural health ingredients, driven by the trends in Asia. To put this in perspective, Euromed's Head of Scientific Communication & Medical Affairs, Mr Andrea Zangara, talks about current trends, the company’s latest products, as well as future plans and actions. Looking back at 2023, what would you consider the highlights for your company in Asia Pacific? It has been really busy. With regards to scientific updates, there are several studies currently underway. For instance, two clinical trials with Pomanox®, our pomegranate fruit extract, are focusing on its benefits for beauty and healthy ageing. The results will potentially have a huge impact on the Asian market, too. In addition, we showcased our recently launched new botanical extracts at Vitafoods Asia in Thailand: Spisar® and CuberUp®, derived from spinach and cucumber respectively, are known for their joint and muscle health benefits. These extracts are also ...